Angelo Scopelianos - Jul 19, 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Chief R&D Officer
Signature
/s/ Angelo Scopelianos
Stock symbol
AXGN
Transactions as of
Jul 19, 2021
Transactions value $
-$12,230
Form type
4
Date filed
7/21/2021, 04:14 PM
Next filing
Dec 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Award $0 +2.57K +31.42% $0.00 10.8K Jul 19, 2021 Direct F1
transaction AXGN Common Stock Tax liability -$12.2K -637 -5.92% $19.20 10.1K Jul 20, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria.
F2 The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on July 19, 2021.